Provided by Tiger Trade Technology Pte. Ltd.

Devonian Health Group Inc.

0.0711
0.0000
Volume:- -
Turnover:- -
Market Cap:196.64K
PE:-0.04
High:0.0711
Open:0.0711
Low:0.0711
Close:0.0711
52wk High:10.80
52wk Low:0.0711
Shares:2.77M
Float Shares:2.12M
Volume Ratio:0.26
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9540
EPS(LYR):-0.3475
ROE:-59.92%
ROA:-4.59%
PB:0.03
PE(LYR):-0.20

Loading ...

Company Profile

Company Name:
Devonian Health Group Inc.
Exchange:
OTCQB
Establishment Date:
- -
Employees:
10
Office Location:
360, rue des Entrepreneurs,Montmagny,Québec,Quebec,Canada
Website:
- -
Zip Code:
G5V 4T1
Fax:
- -
Introduction:
Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, completed Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, the company acquires drug and health product licenses; and distributes pharmaceutical products. Devonian Health Group Inc. was incorporated in 2015 and is headquartered in Québec, Canada.